RXBIO, INC.

Organization

JOHNSON CITY, TN, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Crystalline salts of (Z)-O-octadec-9-en-1-yl O,O-dihydrogen phospho...
- Patent number 9,567,288
- Issue date Feb 14, 2017
- RxBio, Inc.
- Rama Krishna Reddy Singidi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
LPA receptor agonists and antagonists
- Patent number 8,686,177
- Issue date Apr 1, 2014
- RxBio, Inc.
- Veeresh Gududuru
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHO...
- Publication number 20170226139
- Publication date Aug 10, 2017
- RxBio Inc.
- Rama Krishna Reddy Singidi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOSUPPRESSIVE COMPOUNDS AND THERAPEUTICS
- Publication number 20160175281
- Publication date Jun 23, 2016
- UNIVERSITY OF TENNESSE RESEARCH FOUNDATION
- Duane Douglas Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHO...
- Publication number 20150183726
- Publication date Jul 2, 2015
- RxBio Inc.
- Rama Krishna Reddy Singidi
- C07 - ORGANIC CHEMISTRY

NIH Research Projectlast 12 months

processing...

Count: 14

Research Projects

Information Research Project
Targeted Therapies for the Treatment of GI-ARS Diarrhea
- Application id 10008169
- Award notice date Sep 17, 2020
Information Research Project
The anti-diarrheal potential of a LPA analog Rx100
- Application id 9047914
- Award notice date Sep 16, 2015
Information Research Project
Development of Rx100 as Novel Medical Countermeasure for Acute Radi...
- Application id 8903014
- Award notice date Feb 26, 2015
Information Research Project
Radioprotective / Radiomitigating Efficacy of Rx100 in the Gastroin...
- Application id 7862720
- Award notice date Jul 22, 2009
Information Research Project
Development of an LPA receptor modulator Rx100 as a radioprotectant
- Application id 7479472
- Award notice date Jun 27, 2008
Information Research Project
Radioprotective / Radiomitigating Efficacy of Rx100 in the Gastroin...
- Application id 7472935
- Award notice date Aug 11, 2007
Information Research Project
LPA Receptor Modulators as Radioprotectants
- Application id 7326663
- Award notice date Jun 26, 2007
Information Research Project
Development of Medical Countermeasures to Mitigate or Treat GI-ARS
- Application id 9430263
Information Research Project
IND-Enabling Development of Rx100 as a Medical Countermeasure for G...
- Application id 9790011
Information Research Project
Development of Medical Countermeasures to Mitigate or Treat GI-ARS
- Application id 9131561
Information Research Project
Development of Medical Countermeasures to Mitigate or Treat GI-ARS
- Application id 9616155
Information Research Project
Development of Medical Countermeasures to Mitigate or Treat GI-ARS
- Application id 8895139
Information Research Project
Development of Medical Countermeasures to Mitigate or Treat GI-ARS
- Application id 8752310
Information Research Project
TAS::75 0849::TAS
- Application id 8341331

RXBIO, INC.

Organization

Patents Grantslast 30 patents

Crystalline salts of (Z)-O-octadec-9-en-1-yl O,O-dihydrogen phospho...

LPA receptor agonists and antagonists

Patents Applicationslast 30 patents

CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHO...

IMMUNOSUPPRESSIVE COMPOUNDS AND THERAPEUTICS

CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHO...

NIH Research Projectlast 12 months

Research Projects

Targeted Therapies for the Treatment of GI-ARS Diarrhea

The anti-diarrheal potential of a LPA analog Rx100

Development of Rx100 as Novel Medical Countermeasure for Acute Radi...

Radioprotective / Radiomitigating Efficacy of Rx100 in the Gastroin...

Development of an LPA receptor modulator Rx100 as a radioprotectant

Radioprotective / Radiomitigating Efficacy of Rx100 in the Gastroin...

LPA Receptor Modulators as Radioprotectants

Development of Medical Countermeasures to Mitigate or Treat GI-ARS

IND-Enabling Development of Rx100 as a Medical Countermeasure for G...

Development of Medical Countermeasures to Mitigate or Treat GI-ARS

Development of Medical Countermeasures to Mitigate or Treat GI-ARS

Development of Medical Countermeasures to Mitigate or Treat GI-ARS

Development of Medical Countermeasures to Mitigate or Treat GI-ARS

TAS::75 0849::TAS